Catalogo dei prodotti della ricerca

MENICHELLI, DANILO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.779
EU - Europa 1.187
AS - Asia 693
SA - Sud America 92
AF - Africa 39
OC - Oceania 4
Totale 3.794
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.753
IT - Italia 617
SG - Singapore 471
BR - Brasile 83
SE - Svezia 83
IN - India 81
RU - Federazione Russa 76
CN - Cina 75
AT - Austria 67
DE - Germania 65
FI - Finlandia 57
GB - Regno Unito 47
TG - Togo 30
NL - Olanda 26
IE - Irlanda 25
ID - Indonesia 23
CA - Canada 20
FR - Francia 20
RO - Romania 20
BG - Bulgaria 19
HK - Hong Kong 17
UA - Ucraina 14
CH - Svizzera 8
GR - Grecia 8
BE - Belgio 7
ES - Italia 6
MX - Messico 6
EE - Estonia 5
PH - Filippine 5
AU - Australia 4
PL - Polonia 4
MK - Macedonia 3
ZA - Sudafrica 3
AR - Argentina 2
CL - Cile 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EC - Ecuador 2
EG - Egitto 2
IQ - Iraq 2
JP - Giappone 2
LT - Lituania 2
NP - Nepal 2
SI - Slovenia 2
TH - Thailandia 2
TR - Turchia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
DK - Danimarca 1
HU - Ungheria 1
JO - Giordania 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MA - Marocco 1
MY - Malesia 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
SC - Seychelles 1
VE - Venezuela 1
VN - Vietnam 1
Totale 3.794
Salva come PNG Salva come JPEG
Città #
Fairfield 280
Singapore 243
Rome 193
Ashburn 141
Chandler 130
Seattle 119
Houston 117
Wilmington 104
Woodbridge 95
Santa Clara 90
Cambridge 81
San Paolo di Civitate 78
Vienna 54
Princeton 51
Helsinki 41
Ann Arbor 40
Lawrence 39
Millbury 38
Cosenza 36
San Diego 34
Milan 31
Lomé 30
Dublin 25
Dearborn 24
Jakarta 23
Moscow 21
New York 19
Sofia 19
Beijing 17
Fremont 17
Hong Kong 17
Naples 15
Nuremberg 15
Plano 14
Boston 13
Florence 13
London 13
Pescara 13
Toronto 13
Falkenstein 12
Andover 10
Düsseldorf 9
Boardman 8
Hyderabad 8
Lappeenranta 8
Norwalk 7
St Petersburg 7
Athens 6
Corinaldo 6
Council Bluffs 6
Los Angeles 6
Phoenix 6
Portsmouth 6
Shanghai 6
Amsterdam 5
Brussels 5
Dallas 5
Frankfurt am Main 5
Salerno 5
Washington 5
Yubileyny 5
Avellino 4
Bremen 4
Charlotte 4
Denver 4
Madrid 4
Mannheim 4
Perugia 4
Pordenone 4
Saint Etienne 4
São Paulo 4
Terni 4
Alzate Brianza 3
Bologna 3
Buffalo 3
Bühl 3
Chieti 3
Dongguan 3
Edinburgh 3
Hefei 3
Jacksonville 3
Lauterbourg 3
Manchester 3
Messina 3
Montreal 3
Paceco 3
Porto Alegre 3
Redwood City 3
Renens 3
Southend 3
Sulmona 3
Tanza 3
Trieste 3
Turku 3
Algiers 2
Alimos 2
Aubusson 2
Bacoli 2
Bangkok 2
Bari 2
Totale 2.624
Salva come PNG Salva come JPEG
Nome #
Relationship of PCSK9 and urinary thromboxane excretion to cardiovascular events in patients with atrial fibrillation 136
Interaction between serum endotoxemia and proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with atrial fibrillation. a post-hoc analysis from the ATHERO-AF cohort 118
Aging-Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation 115
Is there an interplay between adherence to mediterranean diet, antioxidant status, and vascular disease in atrial fibrillation patients? 113
Gut-Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet 112
Features of severe COVID-19. a systematic review and meta-analysis 111
Adherence to the 'atrial fibrillation better care' pathway in patients with atrial fibrillation. impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients 106
Statins and major adverse limb events in patients with peripheral artery disease. a systematic review and meta-analysis 103
Anti Xa oral anticoagulants inhibit in vivo platelet activation by modulating glycoprotein VI shedding 101
Cancer-specific ischemic complications in elderly Patients with atrial fibrillation. data from the prospective ATHERO-AF study 89
Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants 89
How to treat patients with splanchnic vein thrombosis. recent advances 87
A comprehensive review of risk factors for venous thromboembolism. from epidemiology to pathophysiology 87
Hazelnut and cocoa spread improves flow-mediated dilatation in smokers 83
Fibrosis-4 (FIB-4) index and mortality in COVID-19 patients admitted to the emergency department 80
Relationship of Antiphospholipid Antibodies to Risk of Dementia: A Systematic Review 79
Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes. insights from the multicenter START-ANTIPLATELET registry 79
Integrated care management of patients with atrial fibrillation and risk of cardiovascular events. the abc (atrial fibrillation better care) pathway in the ATHERO-AF study cohort 78
Tailored practical management of patients with atrial fibrillation. a risk factor-based approach 77
Oxidative stress and cardiovascular disease: New insights 73
Silybin and metabolic disorders 73
Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation 71
Update and unmet needs on the use of nonvitamin k oral anticoagulants for stroke prevention in patients with atrial fibrillation 67
Direct oral anticoagulants and advanced liver disease. a systematic review and meta-analysis 67
Relation of atrial fibrillation to angiographic characteristics and coronary artery disease severity in patients undergoing percutaneous coronary intervention 67
Family history of atrial fibrillation and risk of cardiovascular events. a multicenter prospective cohort study 66
Comparison of anticoagulation quality between acenocoumarol and warfarin in patients with mechanical prosthetic heart valves. insights from the nationwide plectrum study 65
Statin liver safety in non-alcoholic fatty liver disease: a systematic review and metanalysis 65
The atrial fibrillation better Care (ABC) pathway and cardiac complications in atrial fibrillation: a potential sex-based difference. the ATHERO-AF study 62
Atrial fibrillation pattern, left atrial diameter and risk of cardiovascular events and mortality. a prospective multicenter cohort study 62
Seronegative antiphospholipid syndrome: Refining the value of “non-criteria” antibodies for diagnosis and clinical management 61
Determinants of low-quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. the nationwide PLECTRUM study 61
Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. a prospective multicenter cohort study 60
Real-world safety and efficacy of direct oral anticoagulants in atrial fibrillation. a network metanalysis on 605,771 patients 60
Association of different oral anticoagulants use with renal function worsening in patients with atrial fibrillation. a multicentre cohort study 59
Cancer and atrial fibrillation. epidemiology, mechanisms, and anticoagulation treatment 59
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Advanced Liver Disease: An Exploratory Meta-Analysis 58
Multiple arterial thrombosis in seronegative antiphospholipid syndrome. need for new diagnostic criteria 56
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF). a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study 52
Long-term risk of major adverse cardiac events in atrial fibrillation patients on direct oral anticoagulants 49
Circulating lipopolysaccharides and impaired antioxidant status in patients with atrial fibrillation. data from the athero-af study 47
Sex-based difference in anticoagulated patients with mechanical prosthetic heart valves and long-term mortality risk 44
Serum albumin and risk of cardiovascular events in primary and secondary prevention: a systematic review of observational studies and Bayesian meta-regression analysis 43
Use of direct oral anticoagulants in patients with antiphospholipid syndrome. a systematic review and comparison of the international guidelines 41
Minimizing drug-drug interactions between dabigatran and levetiracetam through clinical management. a case report 37
Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes. from the START antiplatelet registry 37
Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer. a nationwide cohort study 37
Mediterranean diet: a tool to break the relationship of atrial fibrillation with the metabolic syndrome and non-alcoholic fatty liver disease 37
A systematic review and a meta-analysis comparing prophylactic and therapeutic low molecular weight heparins for mortality reduction in 32,688 COVID-19 patients 36
Efficacy and safety of combination therapy with low-dose rivaroxaban in patients with cardiovascular disease. A systematic review and meta-analysis of randomized controlled trials 33
Incidence of all-cause, cardiovascular, and atrial fibrillation-related hospitalizations 33
Risk of venous thromboembolism in autoimmune diseases. A comprehensive review 33
Clinical phenotypes of atrial fibrillation and mortality risk-a cluster analysis from the nationwide italian START registry 33
Bleeding and thrombotic events in atrial fibrillation patients with cancer. a systematic review and meta-analysis 32
Bleeding and mortality risk in patients implanted with mechanical prosthetic heart valves with and without thrombocytopenia. insights from the nationwide PLECTRUM registry 28
Association of proprotein convertase subtilisin/kexin type 9 (PCSK9) levels with abnormally high ankle-brachial index in atrial fibrillation 27
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes. insights from the START-ANTIPLATELET registry 27
Acute upper and lower gastrointestinal bleeding management in older people taking or not taking anticoagulants: a literature review 26
Factor V Leiden, prothrombin, MTHFR, and PAI-1 gene polymorphisms in patients with arterial disease. A comprehensive systematic-review and meta-analysis 25
Serum albumin, clotting activation and COVID-19 severity: a systematic review and meta-regression analysis of 4579 patients 25
Inositol and Non-Alcoholic Fatty Liver Disease: A Systematic Review on Deficiencies and Supplementation 21
Incident thrombocytopenia and bleeding risk in elderly patients with atrial fibrillation on direct oral anticoagulants: insights from the ATHEROsclerosis in Atrial Fibrillation study 21
Venous Thromboembolism in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis of 4,170,027 Patients 20
Usefulness of the C2HEST score to predict new onset atrial fibrillation. a systematic review and meta‐analysis on >11 million subjects 20
Low platelet count at admission has an adverse impact on outcome in patients with acute coronary syndromes. from the START antiplatelet registry 19
Plasma Concentrations of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Different Degrees of Obesity 18
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism. the apidulcis study 18
Prediction of new-onset atrial fibrillation with the C2HEST score in patients admitted with community-acquired pneumonia 17
Venous thromboembolism secondary to hospitalization for COVID-19: patient management and long-term outcomes 15
Long-term risk of hospitalization and death in patients with mechanical prosthetic heart valves 15
Efficacy and safety of direct oral anticoagulants in the pediatric population: a systematic review and a meta-analysis 14
Gut barrier dysfunction and endotoxemia in heart failure: A dangerous connubium? 13
Renin‐angiotensin-aldosterone system inhibitors and mortality risk in elderly patients with atrial fibrillation. insights from the nationwide START registry 12
More early bleeds associated with high baseline direct oral anticoagulant levels in atrial fibrillation. the MAS study 12
Neutrophil to lymphocyte ratio (NLR) and short-term mortality risk in elderly acute medical patients admitted to a university hospital emergency department 11
Factor V leiden thrombophilia 10
Statins under-treatment and mortality in patients with atrial fibrillation. insights from the nationwide START registry 10
Long-term left ventricular thrombosis resolution in patients receiving vitamin k antagonists: a multicenter observational study 9
Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses 8
Age related clinical efficacy of aspirin for primary cardiovascular prevention: a systematic-review and meta-analysis 7
Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry 5
Patients with antiphospholipid syndrome and a first venous or arterial thrombotic event: clinical characteristics, antibody profiles and estimate of the risk of recurrence 4
Statins as an Adjunctive Antithrombotic Agent in Thrombotic Antiphospholipid Syndrome: Mechanisms and Clinical Implications 4
The severity of ischemic stroke and risk of all-cause mortality in patients with atrial fibrillation on different oral anticoagulant treatments admitted to the emergency department 1
Totale 4.141
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.631
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.631
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202049 0 0 0 0 0 0 0 0 0 0 34 15
2020/2021503 31 17 56 42 4 22 50 13 57 97 79 35
2021/2022578 20 20 47 22 69 39 12 48 36 35 113 117
2022/2023723 109 181 51 66 59 62 9 68 42 18 50 8
2023/2024479 14 55 24 37 45 57 13 50 31 50 53 50
2024/20251.288 55 26 101 103 126 124 98 169 263 203 20 0
Totale 4.141